Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Veropharm Jumps to 2 Month-High on Sistema Buyout: Moscow Mover

OAO Veropharm surged to a two-month high after billionaire Vladimir Evtushenkov’s AFK Sistema won approval to acquire the Russian drugmaker.

The shares gained as much as 11 percent and closed up 8.5 percent at 858.50 rubles in Moscow, the strongest price since Sept. 19. The number of shares traded reached 32,455, equivalent to about 8.5 times the stock’s three-month average.

Russia’s Federal Anti-Monopoly Service granted Sistema permission to acquire all of the Veropharm, the watchdog said in a statement today. OAO Pharmacy Chain 36.6, Russia’s biggest drugstore chain, rallied 4.2 percent to 34.75 rubles, after rising as much as 11 percent. The company aims to sell its 51.8 percent stake in Veropharm to pay down debt, Vedomosti reported Nov. 2.

“Minority investors are hoping Sistema will buy them out at a premium,” Mikhail Terentiev, an analyst at Otkritie Capital in Moscow, said by phone. “The federal approval is just the first step, now the price discussions begin.”

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.